AMILI is a company at the forefront of microbiome research and healthcare innovation, aiming to help us reshape the way we think about our gut health.
As Asia’s first and only gut microbiome transplant bank, AMILI is on a mission to build the world’s largest multi-ethnic microbiome database, focusing specifically on the diverse populations of Southeast Asia.
On The Right Business, Hongbin Jeong speaks with Zat, Editor-in-Chief, The Peak Singapore to find out more.

The Big Story: UAE exits OPEC - Is this a big blow to the oil cartel?
18:00

Wealth Tracker: Is the silver market more dependent on paper than physical metal today?
14:41

What’s Trending: The ‘do-nothing’ job that pays $80k and a dessert the size of a skyscraper
17:15